A Phase 1b Study to Assess Sitravatinib in Combination With Tislelizumab in Participants With Advanced Solid Tumors

NCT03666143 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

216

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: Sitravatinib
DRUG: Tislelizumab

Sponsor

BeiGene